menu search

Spartannash (sptn) lined for q3 earnings: here's what to expect

Spartannash's (SPTN) third-quarter 2023 sales results are likely to reflect gains from the sturdy execu...

November 3, 2023, 12:47 pm

Rocket companies, inc. (rkt) q3 2023 earnings call transcript

Rocket Companies, Inc. (NYSE:RKT ) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Sharon Ng - VP, IR Varun Krishna ...

November 2, 2023, 7:36 pm

Dollar general mistreats breastfeeding mothers, alleges complaint filed by siri & glimstad under the pump act

nashVILLE, Tenn., Oct. 31, 2023 (GLOBE NEWSWIRE) — Two former employees of Dollar General are bringin...

October 31, 2023, 8:23 pm

Icad to report third quarter 2023 financial results on november 13, 2023

nashUA, N.H., Oct. 30, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) is a global leader on a missi...

October 30, 2023, 8:00 am

Universal music group n.v. (umgnf) q3 2023 earnings call transcript

Universal Music Group N.V. (OTCPK:UMGNF) Q3 2023 Earnings Conference Call October 26, 2023 12:15 PM ET Company Participants Lucian Grainge - Chairman ...

October 27, 2023, 5:41 pm

Capital one financial corporation (cof) q3 2023 earnings call transcript

Capital One Financial Corporation (NYSE:COF ) Q3 2023 Earnings Conference Call October 26, 2023 5:00 PM ET Company Participants Jeff Norris - SVP, Fin...

October 26, 2023, 10:13 pm

89bio's low price presents an opportunity

89bio, Inc. stock dropped along with other nash players after Akero's efruxifermin failed a phase 2 tri...

October 26, 2023, 2:15 pm

Altimmune to present new data on the anti-inflammatory and anti-fibrotic properties of pemvidutide in a late-breaking presentation at the liver meeting® 2023

GAITHERSBURG, Md., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that n...

October 25, 2023, 7:30 am

Bio-key sponsors industry-leading cybersecurity conference, isc2 security congress 2023, in nashville, tn, october 25 – 27, 2023 (booth #113)

Showcasing cutting-edge phoneless, tokenless, and passwordless IAM solutions nashVILLE. Tenn. and HOLMD...

October 24, 2023, 10:12 pm

Lipocine to present at the h.c. wainwright annual nash investor conference

SALT LAKE CITY , Oct. 23, 2023 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (C...

October 23, 2023, 7:00 pm

Galectin therapeutics to participate in the h.c. wainwright 7th annual nash investor conference on october 24, 2023

NORCROSS, Ga., Oct. 23, 2023 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin...

October 23, 2023, 8:00 am

Healthcare realty trust announces third quarter earnings release date and conference call

nashVILLE, Tenn., Oct. 20, 2023 (GLOBE NEWSWIRE) — Healthcare Realty Trust Incorporated (NYSE:HR) tod...

October 20, 2023, 10:38 pm

Healthcare realty trust announces third quarter earnings release date and conference call

nashVILLE, Tenn., Oct. 20, 2023 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) toda...

October 20, 2023, 6:38 pm

Terns pharmaceuticals to participate in upcoming investor conferences

FOSTER CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stag...

October 19, 2023, 8:05 pm

Crescent communities announces the sale of two communities to ta realty

NOVEL Harpeth Heights and NOVEL Cary continue to see immense success and interest CARY, N.C. and nashVI...

October 19, 2023, 6:22 pm

Sagimet biosciences to present at the h.c. wainwright 7th annual nash investor conference

SAN MATEO, Calif., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing no...

October 18, 2023, 4:05 pm

Neurobo to present at the h.c. wainwright 7th annual nash investor conference

BOSTON , Oct. 17, 2023 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company on a quest to transform ca...

October 17, 2023, 8:01 am

89bio to participate in the h.c. wainwright 7ᵗʰ annual nash investor conference

SAN FRANCISCO, Oct. 17, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and...

October 17, 2023, 8:00 am

Why akero therapeutics shares are slumping this week

Akero only has one drug in clinical trials. The company said the drug didn't meet its primary endpoint of slowing ...

October 12, 2023, 4:38 pm

Akero (akro) slumps 63% on mixed results from nash study

Data from a mid-stage study shows that Akero Therapeutics' (AKRO) lead candidate failed to achieve statistical significance in its primary endpoint of...

October 11, 2023, 12:47 pm


Search within

Pages Search Results: